CD274 and neoplasm: Immune-induced tumor PD-L1 expression is considered to be an adaptive resistance mechanism by tumor cells in response to immune challenge, and PD-L1 expression can also be regulated by intrinsic oncogenic pathways, microRNA, genetic alterations, and post-translational regulation (Zou et al., 2016; Sun et al., 2018).